Login / Signup

Contribution of BHG and PPHG to Overall Hyperglycemia in T2DM Patients Treated with LM25 and LM50: Post Hoc Analysis of a Randomized Crossover Trial.

Wei LiFan PingLingling XuHuabing ZhangYaxiu DongHongmei LiQi SunYu-Xiu Li
Published in: Diabetes therapy : research, treatment and education of diabetes and related disorders (2018)
Lilly Suzhou Pharmaceutical Co., Ltd. (Shanghai Branch, China) and National Key Program of Clinical Science of China (WBYZ2011-873).
Keyphrases
  • quality improvement
  • public health
  • clinical trial
  • open label
  • phase iii
  • randomized controlled trial
  • phase ii
  • type diabetes
  • oxidative stress
  • skeletal muscle
  • diabetic rats